Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Oracle Corporation (ORCL) -- Ignore unavailable to you. Want to Upgrade?

To: Orlando Stevenson who wrote (11238)	6/21/1999 1:29:00 AM
From: OverSold	Respond to of 19080

Oracle ERP Chosen!! Edit Personal News Alerts Edit Personal Stock Alerts View Personal News Alerts View Personal Summary Download Personal Notifier Click on printer icon on your browser to print story Golden Pharmaceuticals, Inc. -- GPHI -- Announces Technology Partners for E-commerce Business Wire - June 20, 1999 22:45 SANTA ANA, Calif.--(BW HealthWire)--June 19, 1999--Golden Pharmaceuticals, Inc. ("Golden")(OTC BB:GPHI) today announced the signing of technology agreements for the implementation of its e-commerce services to physicians' offices and clinics. BroadVision will provide its One-to-One Commerce solution that will allow the Company to personalize its customers' Internet purchasing experiences. Oracle Applications was chosen as the ERP (enterprise resource planning) solution to provide the infrastructure necessary to support the projected increase in sales volume. Sun Microsystems will be providing the servers to drive the applications. Chuck Drummond, Chairman and CEO of Golden, said that "this set of outstanding software and hardware suppliers will provide us with state-of-the-art service capability to greatly expand our product and service offerings to physicians and their staffs across the country. The select set of implementation consultants we have chosen will assure both the high quality and timeliness that our numerous customers have come to expect." Golden currently operates primarily through its Quality Care Pharmaceuticals, Inc. subsidiary and sells prescription and OTC (over-the-counter) medications and related software to physicians' offices, clinics and other healthcare facilities. Golden's recent Proxy announced its intention to change its name to more accurately communicate its growing emphasis on e-commerce. CONTACT: Golden Pharmaceuticals, Inc., Santa Ana

To: Orlando Stevenson who wrote (11238)	6/21/1999 8:48:00 AM
From: MeDroogies	Read Replies (2) \| Respond to of 19080

Just my 2 cents (and my poor history w/options is well known), but I think that we're going to stick to a $2 range either way for a while. That might be good enough for your options, but that's up to you. I think the flurry of activity last week wore out interest in ORCL for the time being. It's gonna take some big news - or some big industry news - for ORCL to move again. Again, I'm probably wrong, based on my history of playing the short term market.